Hypothesizing that part of these cells could be tumor-reactive, we analyzed tumor infiltrating T cells from an HLA-A2+ HNSCC patient for their capacity to bind an HLA-A2 pentamer loaded with G250/CAIX, a tumor antigen frequently expressed by HNSCC cells [38]. This evidence concerns the gene CA9 and head and neck squamous cell carcinoma.